The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Nevus, Pigmented

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Nevus, Pigmented


High impact information on Nevus, Pigmented


Chemical compound and disease context of Nevus, Pigmented


Biological context of Nevus, Pigmented


Anatomical context of Nevus, Pigmented


Gene context of Nevus, Pigmented


Analytical, diagnostic and therapeutic context of Nevus, Pigmented


  1. MUC18, a marker of tumor progression in human melanoma, shows sequence similarity to the neural cell adhesion molecules of the immunoglobulin superfamily. Lehmann, J.M., Riethmüller, G., Johnson, J.P. Proc. Natl. Acad. Sci. U.S.A. (1989) [Pubmed]
  2. Versican is differentially expressed in human melanoma and may play a role in tumor development. Touab, M., Villena, J., Barranco, C., Arumí-Uría, M., Bassols, A. Am. J. Pathol. (2002) [Pubmed]
  3. Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas. Vogt, T., Stolz, W., Welsh, J., Jung, B., Kerbel, R.S., Kobayashi, H., Landthaler, M., McClelland, M. Clin. Cancer Res. (1998) [Pubmed]
  4. In vitro complement binding in human skin cells with altered differentiation. Hintner, H., Stanzl, U., Schuler, G., Klein, G., Fritsch, P., Stingl, G. J. Invest. Dermatol. (1983) [Pubmed]
  5. Melanoma in children. Roth, M.E., Grant-Kels, J.M., Kuhn, M.K., Greenberg, R.D., Hurwitz, S. J. Am. Acad. Dermatol. (1990) [Pubmed]
  6. A major quantitative-trait locus for mole density is linked to the familial melanoma gene CDKN2A: a maximum-likelihood combined linkage and association analysis in twins and their sibs. Zhu, G., Duffy, D.L., Eldridge, A., Grace, M., Mayne, C., O'Gorman, L., Aitken, J.F., Neale, M.C., Hayward, N.K., Green, A.C., Martin, N.G. Am. J. Hum. Genet. (1999) [Pubmed]
  7. Identification of the human PHLDA1/TDAG51 gene: down-regulation in metastatic melanoma contributes to apoptosis resistance and growth deregulation. Neef, R., Kuske, M.A., Pröls, E., Johnson, J.P. Cancer Res. (2002) [Pubmed]
  8. Development and characterization of a mouse monoclonal antibody, MoAb HMSA-1, against a melanosomal fraction of human malignant melanoma. Akutsu, Y., Jimbow, K. Cancer Res. (1986) [Pubmed]
  9. Characterization of methylthioadenosin phosphorylase (MTAP) expression in malignant melanoma. Behrmann, I., Wallner, S., Komyod, W., Heinrich, P.C., Schuierer, M., Buettner, R., Bosserhoff, A.K. Am. J. Pathol. (2003) [Pubmed]
  10. Expression of transforming growth factor-beta 2 in malignant melanoma correlates with the depth of tumor invasion. Implications for tumor progression. Reed, J.A., McNutt, N.S., Prieto, V.G., Albino, A.P. Am. J. Pathol. (1994) [Pubmed]
  11. Increased nevus estrogen and progesterone ligand binding related to oral contraceptives or pregnancy. Ellis, D.L., Wheeland, R.G. J. Am. Acad. Dermatol. (1986) [Pubmed]
  12. Estrogen and progesterone receptors in congenital melanocytic nevi. Ellis, D.L., Wheeland, R.G., Solomon, H. J. Am. Acad. Dermatol. (1985) [Pubmed]
  13. Topical chemotherapy of dysplastic melanocytic nevi with 5% fluorouracil. Bondi, E.E., Clark, W.H., Elder, D., Guerry, D., Greene, M.H. Archives of dermatology. (1981) [Pubmed]
  14. Clinical and histological responses of congenital melanocytic nevi after single treatment with Q-switched lasers. Grevelink, J.M., van Leeuwen, R.L., Anderson, R.R., Byers, H.R. Archives of dermatology. (1997) [Pubmed]
  15. UV induction of cyclobutane thymine dimers in the DNA of cultured melanocytes from foreskin, common melanocytic nevi and dysplastic nevi. Noz, K.C., Roza, L., Bergman, W., Darroudi, F., Schothorst, A.A. Photochem. Photobiol. (1994) [Pubmed]
  16. Comparison of cell-mediated immunity to melanoma cells in patients with vitiligo, halo nevi or melanoma. Mitchell, M.S., Nordlund, J.J., Lerner, A.B. J. Invest. Dermatol. (1980) [Pubmed]
  17. BRAF mutations are common somatic events in melanocytic nevi. Kumar, R., Angelini, S., Snellman, E., Hemminki, K. J. Invest. Dermatol. (2004) [Pubmed]
  18. S100A6 protein expression is different in Spitz nevi and melanomas. Ribé, A., McNutt, N.S. Mod. Pathol. (2003) [Pubmed]
  19. A search for CDKN2A/p16INK4a mutations in melanocytic nevi from patients with melanoma and spouse controls by use of laser-captured microdissection. Wang, H., Presland, R.B., Piepkorn, M. Archives of dermatology. (2005) [Pubmed]
  20. Alterations of mismatch repair protein expression in benign melanocytic nevi, melanocytic dysplastic nevi, and cutaneous malignant melanomas. Hussein, M.R., Roggero, E., Sudilovsky, E.C., Tuthill, R.J., Wood, G.S., Sudilovsky, O. The American Journal of dermatopathology. (2001) [Pubmed]
  21. Aberrant expression of the maspin gene associated with epigenetic modification in melanoma cells. Wada, K., Maesawa, C., Akasaka, T., Masuda, T. J. Invest. Dermatol. (2004) [Pubmed]
  22. ASC/TMS1, a caspase-1 activating adaptor, is downregulated by aberrant methylation in human melanoma. Guan, X., Sagara, J., Yokoyama, T., Koganehira, Y., Oguchi, M., Saida, T., Taniguchi, S. Int. J. Cancer (2003) [Pubmed]
  23. Differential expression of the intermediate filament peripherin in cutaneous neural lesions and neurotized melanocytic nevi. Prieto, V.G., McNutt, N.S., Lugo, J., Reed, J.A. Am. J. Surg. Pathol. (1997) [Pubmed]
  24. Typical halo nevi in childhood: is a biopsy necessary? Yes, but perhaps from the duodenum! Marthinsen, L., Nilsson, N.O. J. Pediatr. (2005) [Pubmed]
  25. Expression of proliferating cell nuclear antigen in Spitz nevus. Penneys, N., Seigfried, E., Nahass, G., Vogler, C. J. Am. Acad. Dermatol. (1995) [Pubmed]
  26. Lack of association between BRAF mutation and MAPK ERK activation in melanocytic nevi. Uribe, P., Andrade, L., Gonzalez, S. J. Invest. Dermatol. (2006) [Pubmed]
  27. MMP-2, TIMP-2 and MT1-MMP are differentially expressed in lesional skin of melanocytic nevi and their expression is modulated by UVB-light. Krengel, S., Alexander, M., Brinckmann, J., Tronnier, M. J. Cutan. Pathol. (2002) [Pubmed]
  28. Neurofibromas and neurotized melanocytic nevi are immunohistochemically distinct neoplasms. Gray, M.H., Smoller, B.R., McNutt, N.S., Hsu, A. The American Journal of dermatopathology. (1990) [Pubmed]
  29. Spitz nevi and atypical Spitz nevi/tumors: a histologic and immunohistochemical analysis. Kapur, P., Selim, M.A., Roy, L.C., Yegappan, M., Weinberg, A.G., Hoang, M.P. Mod. Pathol. (2005) [Pubmed]
  30. Limitations of dermoscopy in the recognition of melanoma. Skvara, H., Teban, L., Fiebiger, M., Binder, M., Kittler, H. Archives of dermatology. (2005) [Pubmed]
  31. Carbon dioxide laser dermabrasion for giant congenital melanocytic nevi. Reynolds, N., Kenealy, J., Mercer, N. Plast. Reconstr. Surg. (2003) [Pubmed]
  32. bcl-2 protein expression in cutaneous malignant melanoma and benign melanocytic nevi. Cerroni, L., Soyer, H.P., Kerl, H. The American Journal of dermatopathology. (1995) [Pubmed]
  33. Human telomerase RNA component expression in Spitz nevi, common melanocytic nevi, and malignant melanomas. Guttman-Yassky, E., Bergman, R., Manov, L., Sprecher, E., Shaefer, Y., Kerner, H. J. Cutan. Pathol. (2002) [Pubmed]
WikiGenes - Universities